Workflow
YTOT(300790)
icon
Search documents
宇瞳光学(300790) - 东兴证券股份有限公司关于东莞市宇瞳光学科技股份有限公司2024年度内部控制自我评价报告的核查意见
2025-04-28 17:11
东兴证券股份有限公司 关于东莞市宇瞳光学科技股份有限公司 自内部控制评价报告基准日至内部控制评价报告发出日之间未发生影响内 部控制有效性评价结论的因素。 二、公司内部控制评价工作情况 (一)内部控制评价范围 公司按照风险导向原则确定纳入评价范围的主要单位、业务和事项以及高风 险领域。纳入评价范围的主要单位包括:东莞市宇瞳光学科技股份有限公司及子 公司上饶市宇瞳光学有限公司、东莞市宇瞳汽车视觉有限公司、江西宇瞳教育科 技发展有限公司、东莞市宇瞳玖洲光学有限公司、东莞市宇承科技有限公司、宇 豪科技(香港)国际有限公司等。纳入评价范围单位资产总额占公司合并财务报 1 2024 年度内部控制自我评价报告的核查意见 东兴证券股份有限公司(以下简称"东兴证券")作为东莞市宇瞳光学科技股 份有限公司(以下简称"宇瞳光学"、"公司"或"发行人")向不特定对象发行 可转换公司债券的保荐机构,根据《证券发行上市保荐业务管理办法》《深圳证 券交易所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号 ——创业板上市公司规范运作》《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等法律法规的规定,东兴证券对 ...
宇瞳光学(300790) - 东兴证券股份有限公司关于东莞市宇瞳光学科技股份有限公司2024年度募集资金存放和使用情况专项核查报告
2025-04-28 17:11
一、公司募集资金基本情况 东兴证券股份有限公司 关于东莞市宇瞳光学科技股份有限公司 2024 年度募集资金存放和使用情况专项核查报告 东兴证券股份有限公司(以下简称"东兴证券"或"保荐机构")作为东莞市宇瞳光 学科技股份有限公司(以下简称"宇瞳光学"或"公司")向不特定对象发行可转换公司 债券的保荐机构,根据《证券发行上市保荐业务管理办法》《上市公司监管指引第 2 号 ——上市公司募集资金管理和使用的监管要求》《深圳证券交易所创业板股票上市规 则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》 《深圳证券交易所上市公司自律监管指引第 13 号——保荐业务》等文件的要求,对宇 瞳光学 2024 年度募集资金存放与使用情况进行了核查,具体情况如下: (一)募集资金金额及到位情况 经中国证券监督管理委员会《关于同意东莞市宇瞳光学科技股份有限公司向不特 定对象发行可转换公司债券注册的批复》(证监许可〔2023〕1382 号)核准,并经深 圳证券交易所同意,公司于 2024 年 8 月 11 日公开发行 6,000,000.00 份可转换公司债 券,每份面值 100 元,发行总额 600,0 ...
宇瞳光学(300790) - 董事会对独董独立性评估的专项意见
2025-04-28 16:40
根据《上市公司独立董事管理办法》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等要求,结合独立董事出具的《独立董事独立性自查 情况表》,经核查,公司董事会认为:认为公司独立董事不存在任何妨碍其进行独立客 观判断的关系,不存在影响独立董事独立性的情况,符合《上市公司独立董事管理办法》 《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市公司规范运作》等法律 法规及《公司章程》中关于独立董事的任职资格及独立性的要求。 东莞市宇瞳光学科技股份有限公司董事会 东莞市宇瞳光学科技股份有限公司 董事会关于独立董事独立性情况的专项意见 2025 年 4 月 28 日 ...
宇瞳光学(300790) - 独立董事述职报告(孔祥婷)
2025-04-28 16:40
东莞市宇瞳光学科技股份有限公司 2024 年度独立董事述职报告 本人孔祥婷,作为东莞市宇瞳光学科技股份有限公司(以下简称"公司") 第三届董事会独立董事,在任职期间严格按照《公司法》《证券法》《公司章程》 及《上市公司独立董事管理办法》等规定,诚实、勤勉、独立地履行独立董事职 责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对公司重大 事项发表了事前认可意见和独立意见,充分发挥了独立董事的作用,切实维护公 司整体利益和全体股东特别是中小股东的合法权益。 报告期内,本人因第三届董事会届满离任,自 2024 年 12 月 23 日起不再担 任公司独立董事及各专门委员会委员职务。现将本人 2024 年度任职期间履行独 立董事职责的情况汇报如下: 一、独立董事的基本情况: 报告期内,本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求,不存在影响独立性的情况。本人履历如下: 孔祥婷女士,独立董事,1983 年 5 月出生,中国国籍,管理学博士。2005 年毕业于武汉大学商学院会计学专业,获管理学学士学位。2014 年毕业于中山 大学管理学院会计学专业,获管理学博士学位。2014 年 9 月至 ...
宇瞳光学(300790) - 公司章程(2025年4月)
2025-04-28 16:40
东莞市宇瞳光学科技股份有限公司 章 程 二〇二五年四月 | | | | 第一章 | 总 | 则 1 | | --- | --- | --- | | 第二章 | | 经营宗旨和范围 2 | | 第三章 | 股 | 份 2 | | 第一节 | | 股份发行 2 | | 第二节 | | 股份增减和回购 3 | | 第三节 | | 股份转让 5 | | 第四章 | | 股东和股东大会 6 | | 第一节 | | 股东 6 | | 第二节 | | 股东大会的一般规定 9 | | 第三节 | | 股东大会的召集 12 | | 第四节 | | 股东大会的提案与通知 13 | | 第五节 | | 股东大会的召开 15 | | 第六节 | | 股东大会的表决和决议 18 | | 第五章 | 董 事 | 会 22 | | 第一节 | | 董事 22 | | 第二节 | 董 事 | 会 25 | | 第六章 | | 总经理及其他高级管理人员 30 | | 第七章 | 监 事 | 会 31 | | 第一节 | 监 | 事 31 | | 第二节 | | 监事会 32 | | 第八章 | | 重大交易决策程序 34 | | 第一节 | ...
宇瞳光学(300790) - 独立董事述职报告(刘冰)
2025-04-28 16:40
东莞市宇瞳光学科技股份有限公司 2024 年度独立董事述职报告 本人刘冰,作为东莞市宇瞳光学科技股份有限公司(以下简称"公司")第 四届董事会独立董事,在任职期间严格按照《公司法》《证券法》《公司章程》 及《上市公司独立董事管理办法》等规定,诚实、勤勉、独立地履行独立董事职 责,积极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对公司重大 事项发表了事前认可意见和独立意见,充分发挥了独立董事的作用,切实维护公 司整体利益和全体股东特别是中小股东的合法权益。现将本人 2024 年度任职期 间履行独立董事职责的情况汇报如下: 一、独立董事的基本情况: 报告期内,本人任职符合《上市公司独立董事管理办法》第六条规定的 独立性要求,不存在影响独立性的情况。本人履历如下: 刘冰女士,独立董事,1981 年 11 月生,中国国籍,无境外永久居留权, 中山大学博士研究生学历,管理学博士学位。现任中山大学商学院教授,博士生 导师,具备财务管理、会计专业教授资格,自 2012 年至今担任财务管理、会计 等课程的授课教师。2024 年 12 月至今担任东莞市宇瞳光学科技股份有限公司独 立董事。 二、独立董事年度履职情况 (一 ...
宇瞳光学(300790) - 独立董事述职报告(杨金才)
2025-04-28 16:40
二、独立董事年度履职情况 (一)出席会议情况 本人在任职后积极参加了公司召开的所有董事会、股东大会,本着勤勉尽责 的态度,认真审阅了会议议案及相关材料,主动参与各议案的讨论并提出合理建 议,为董事会的正确、科学决策发挥积极作用。公司董事会、股东大会的召集召 开符合法定程序,重大经营决策事项和其他重大事项均履行了相关的审批程序。 东莞市宇瞳光学科技股份有限公司 2024 年度独立董事述职报告 本人杨金才,作为东莞市宇瞳光学科技股份有限公司(以下简称"公司") 董事会独立董事,在任职期间严格按照《公司法》《证券法》《公司章程》及《上 市公司独立董事管理办法》等规定,诚实、勤勉、独立地履行独立董事职责,积 极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对公司重大事项发 表了事前认可意见和独立意见,充分发挥了独立董事的作用,切实维护公司整体 利益和全体股东特别是中小股东的合法权益。现将本人 2024 年度任职期间履行 独立董事职责的情况汇报如下: 一、独立董事的基本情况: 报告期内,本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求,不存在影响独立性的情况。本人履历如下: 杨金才先生,1959 ...
宇瞳光学(300790) - 独立董事述职报告(阎磊)
2025-04-28 16:40
东莞市宇瞳光学科技股份有限公司 2024 年度独立董事述职报告 本人阎磊,作为东莞市宇瞳光学科技股份有限公司(以下简称"公司")董 事会独立董事,在任职期间严格按照《公司法》《证券法》《公司章程》及《上 市公司独立董事管理办法》等规定,诚实、勤勉、独立地履行独立董事职责,积 极出席相关会议,认真审议董事会各项议案,并以谨慎的态度对公司重大事项发 表了事前认可意见和独立意见,充分发挥了独立董事的作用,切实维护公司整体 利益和全体股东特别是中小股东的合法权益。现将本人 2024 年度任职期间履行 独立董事职责的情况汇报如下: 一、独立董事的基本情况: 报告期内,本人任职符合《上市公司独立董事管理办法》第六条规定的独立 性要求,不存在影响独立性的情况。本人履历如下: 阎磊先生,独立董事,1973 年 6 月生,中国国籍,无境外永久居留权。武汉 大学民商法学博士学位,最高人民法院、中国社会科学院联合培养博士后。曾供 职于深圳市人民政府法制办公室;北京新时代宏图基金管理有限公司总裁。2015 年 12 月至今,担任深圳兄弟足球投资发展控股有限公司执行董事兼总经理;2024 年 1 月至今,担任深圳政挚数据科技有限公司董 ...
宇瞳光学(300790) - 2025 Q1 - 季度财报
2025-04-28 16:30
Financial Performance - The company's revenue for Q1 2025 was ¥615,162,721.44, representing an increase of 8.18% compared to ¥568,652,493.05 in the same period last year[5]. - Net profit attributable to shareholders was ¥48,848,670.67, up 21.33% from ¥40,261,642.91 year-on-year[5]. - The net profit after deducting non-recurring gains and losses was ¥45,052,687.34, reflecting a growth of 25.49% compared to ¥35,902,353.07 in the previous year[5]. - The company achieved a diluted earnings per share of ¥0.13, an increase of 8.33% from ¥0.12 in the same period last year[5]. - The net profit for the current period is 48,848,668.94, an increase from 46,665,562.16 in the previous period, representing a growth of approximately 4.67%[22]. - Operating profit for the current period is 54,701,503.75, compared to 50,631,508.48 in the previous period, indicating an increase of about 4.2%[22]. - Total comprehensive income attributable to the parent company is 48,602,785.74, compared to 40,555,495.24 in the previous period, marking an increase of about 19.5%[22]. Cash Flow and Investments - The net cash flow from operating activities decreased by 46.35% to ¥52,798,980.28 from ¥98,407,982.90 in the same period last year[5]. - Cash flow from operating activities for the current period is 52,798,980.28, down from 98,407,982.90 in the previous period, a decrease of approximately 46.4%[24]. - Cash flow from investing activities shows a net outflow of -69,330,895.13, compared to -61,172,516.22 in the previous period, indicating a worsening of about 13.5%[25]. - Cash flow from financing activities generated a net inflow of 109,576,156.38, up from 72,085,820.26 in the previous period, reflecting an increase of approximately 52%[25]. - The company received cash from sales of goods and services totaling 562,008,367.45, an increase from 536,996,324.40 in the previous period, representing a growth of about 4.7%[24]. Assets and Liabilities - The company's total assets increased by 1.72% to ¥5,401,323,997.00 from ¥5,309,987,341.18 at the end of the previous year[5]. - Total liabilities rose to ¥2,936,523,290.93, compared to ¥2,902,856,102.83, indicating an increase of 1.2%[19]. - Cash and cash equivalents at the end of the period were ¥654,435,918.42, up from ¥539,829,929.98, representing a growth of 21.2%[18]. - Inventory at the end of the period was ¥645,615,992.30, an increase from ¥580,077,026.24, which is a rise of 11.3%[18]. - Long-term borrowings increased to ¥766,123,682.00 from ¥644,830,620.00, representing a growth of 18.8%[19]. - Deferred income tax assets rose to ¥44,814,536.53 from ¥38,777,153.81, marking an increase of 15.5%[19]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 55,919[13]. - The largest shareholder, Zhang Pingguang, holds 11.41% of shares, totaling 42,674,341 shares, with 32,005,756 shares under pledge[13]. - The company has a repurchase account holding 3,113,500 shares, representing 1.04% of the total share capital[14]. - The total number of restricted shares at the end of the period is 73,908,785, with 644,775 shares added during the period[16]. - The top ten shareholders hold a significant portion of shares, with the largest holding being 11.41%[13]. - The company has implemented a strategy for unlocking restricted shares, with 25% of high-level management shares being released annually[16]. - The shareholder structure indicates a concentration of ownership, with the top ten shareholders holding a substantial percentage of the total shares[13]. - The total number of shares held by the top ten unrestricted shareholders is significant, with Zhang Pingguang and Zhang Hao being notable holders[13]. - The company has not reported any changes in the participation of major shareholders in margin trading or securities lending[15]. - The company has not disclosed any related party transactions among the major shareholders[13]. Research and Development - Research and development expenses increased by 51.87% to ¥37,132,307.12 from ¥24,449,444.59 in the previous year, indicating a significant investment in innovation[9]. - Research and development expenses increased to ¥37,132,307.12, compared to ¥24,449,444.59, marking a growth of 51.6%[21]. Other Financial Metrics - The company incurred a tax expense of 5,631,933.01, compared to 3,529,656.38 in the previous period, reflecting an increase of approximately 60%[22]. - The basic earnings per share remain stable at 0.13, while diluted earnings per share increased from 0.12 to 0.13[22]. - The company reported cash and cash equivalents at the end of the period amounting to 589,107,206.48, up from 482,625,880.32 in the previous period, an increase of approximately 22.1%[25]. - Total operating revenue for the current period reached ¥615,162,721.44, an increase of 8.5% compared to ¥568,652,493.05 in the previous period[21]. - Total operating costs amounted to ¥578,657,486.49, up from ¥540,016,085.14, reflecting a rise of 7.1%[21]. - The company reported a 302.41% increase in credit impairment losses, amounting to ¥9,567,773.63, primarily due to the write-off of bad debts[9]. - The company has seen a 44.55% increase in cash paid to employees, totaling ¥106,248,561.19, attributed to higher salary payments[10].
宇瞳光学(300790) - 2024 Q4 - 年度财报
2025-04-28 16:30
Financial Performance - The company's operating revenue for 2024 reached ¥2,743,355,449.04, representing a 27.90% increase compared to ¥2,144,987,827.40 in 2023[19] - Net profit attributable to shareholders surged to ¥183,561,223.51, a remarkable increase of 494.92% from ¥30,854,897.28 in the previous year[19] - The basic earnings per share rose to ¥0.56, reflecting a 460.00% increase from ¥0.1 in 2023[19] - The total assets of the company at the end of 2024 amounted to ¥5,309,987,341.18, a 5.03% increase from ¥5,055,839,501.43 at the end of 2023[19] - The net assets attributable to shareholders increased by 27.96% to ¥2,407,131,238.35 from ¥1,881,112,559.06 in 2023[19] - Cash flow from operating activities decreased by 38.15% to ¥337,818,094.76 compared to ¥546,213,754.95 in 2023[19] - The company reported a weighted average return on equity of 9.40%, significantly up from 1.63% in the previous year[19] - The net profit after deducting non-recurring gains and losses reached ¥159,434,532.99, a substantial increase of 772.76% from ¥18,267,899.99 in 2023[19] Market and Industry Insights - The global network camera market is projected to grow from $10.21 billion in 2022 to $39.63 billion by 2032, with a CAGR of 14.52% from 2023 to 2032[29] - The sales revenue of automotive lenses is expected to rise from $1.309 billion in 2023 to $1.887 billion by 2027[30] - The Chinese machine vision market is expected to grow from 17.065 billion yuan in 2022 to 56.565 billion yuan by 2027[31] - The company is the largest security lens manufacturer globally, maintaining a market share ranking first for ten consecutive years[32] - The company’s automotive optical products are gaining recognition, with a projected market share of 10.1% in global sales for 2024[32] Product Development and Innovation - The company specializes in the design, research and development, production, and sales of optical lenses, primarily used in public security monitoring equipment, smart home devices, automotive cameras, and machine vision systems[37] - The main business focus is on the security field, with a diverse product range including ultra-star light series, all-in-one series, 4K series, zoom series, star-level fixed-focus series, general fixed-focus series, wide-angle fixed-focus series, fisheye series, and CS series[37] - The company is actively expanding its product offerings in the smart home and machine vision sectors, which are anticipated to grow significantly in the coming years[31] - The company has developed multiple models of fisheye lenses with an effective field of view reaching 200° and supporting 4K high definition resolution[39] - The star-level lenses have improved light transmission, with maximum aperture reaching F0.8, enabling full-color image output even in complete darkness[39] - The company offers a series of low distortion lenses suitable for video conferencing and facial recognition applications, ensuring minimal image distortion[41] - The company has launched a range of automatic focus lenses for mirrorless cameras, emphasizing lightweight design and fast focusing speed[41] - The new product line includes ultra-wide-angle lenses suitable for outdoor and astrophotography, featuring high resolution and minimal distortion[42] Strategic Partnerships and Expansion - The company has established long-term partnerships with major clients such as Hikvision and BYD, enhancing its brand reputation[33] - The company is actively expanding its overseas market presence, having established a subsidiary in Thailand to support international growth[61] - The company has formed long-term stable partnerships with well-known enterprises such as Hikvision, BYD, and Geely, enhancing its market reputation[55] Research and Development - The company holds a total of 847 patents, including 140 invention patents, 626 utility model patents, and 81 design patents[52] - The company has a research and development team of over 500 people, focusing on high-end products such as high-magnification zoom lenses and machine vision lenses[52] - R&D investment amounted to ¥172,804,233.56 in 2024, accounting for 6.30% of operating revenue, compared to 5.69% in 2023[90] - The number of R&D personnel increased to 546 in 2024, up 31.25% from 416 in 2023, representing 17.69% of the total workforce[90] Governance and Management - The company has improved its governance structure and internal management systems in accordance with relevant laws and regulations[137] - The board of directors consists of 9 members, including 3 independent directors, complying with legal requirements[139] - The supervisory board is composed of 3 members, including 1 employee representative, meeting legal standards[141] - The company has established specialized committees within the board, with independent directors holding a majority in most committees[139] - The company has maintained compliance with the requirements of the China Securities Regulatory Commission and the Shenzhen Stock Exchange[137] Financial Management and Investments - The company reported a significant increase in investment amounting to ¥380,500,000.00, a 661.00% increase compared to ¥50,000,000.00 in the same period last year[102] - The company has ongoing major non-equity investments, although specific details were not disclosed[106] - The company has pledged cash and securities amounting to ¥45,182,858.06 as collateral for loans and guarantees[101] - The company raised a total of RMB 60,000.00 million through the issuance of 6 million convertible bonds, with a net amount of RMB 588,750,348.07 after deducting issuance costs[111] Employee Relations and Compensation - The total remuneration for directors, supervisors, and senior management during the reporting period amounted to 742.36 million CNY[172] - The company has a structured remuneration decision-making process involving the compensation and assessment committee[167] - The employee stock ownership plan includes 337 employees holding a total of 6,714,900 shares, representing 2.00% of the company's total share capital[192] - The company emphasizes employee training through various programs to enhance skills and management capabilities[187] Risk Management - The company has outlined potential risks and countermeasures in its future development outlook section, emphasizing the importance of risk awareness for investors[3] - The supervisory board found no risks during the reporting period, indicating effective oversight[184] - The company is addressing potential risks from macroeconomic changes and market competition by enhancing management strategies and increasing R&D investments[128][129]